Alnylam Pharmaceuticals (ALNY) PT Raised to $199 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $229.85 +2.34%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $199.00 (from $162.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Pony AI Inc (PONY) PT Lowered to $17 at BofA Securities
- SmartFinancial (SMBK) PT Raised to $60 at Benchmark on Higher Valuation
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
